Adrian Cassidy leads Evidence Generation within Global Medical Affairs at Novartis, overseeing the organization responsible for generating evidence that informs decisions across the medicine lifecycle, from development through real world use in health systems. With a focus on innovative modalities including small molecules, biologics, siRNA-based therapies, cell and gene therapies, and radioligand therapies across oncology, immunology, neuroscience, and cardio-renal-metabolic diseases, the Evidence Generation organization applies data, AI and technology, and new partnership models to transform how evidence is generated and help health systems adopt breakthrough innovations faster for patients.